FI114897B - Silmän sisäistä painetta alentavan aineen käyttö ja silmätipoiksi tehty lääke - Google Patents

Silmän sisäistä painetta alentavan aineen käyttö ja silmätipoiksi tehty lääke Download PDF

Info

Publication number
FI114897B
FI114897B FI963645A FI963645A FI114897B FI 114897 B FI114897 B FI 114897B FI 963645 A FI963645 A FI 963645A FI 963645 A FI963645 A FI 963645A FI 114897 B FI114897 B FI 114897B
Authority
FI
Finland
Prior art keywords
group
compound
formula
alkyl group
methyl
Prior art date
Application number
FI963645A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963645A0 (fi
FI963645A (fi
Inventor
Tomihisa Yokoyama
Hiroaki Yanagisawa
Tsunemichi Hosokawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI963645A0 publication Critical patent/FI963645A0/fi
Publication of FI963645A publication Critical patent/FI963645A/fi
Application granted granted Critical
Publication of FI114897B publication Critical patent/FI114897B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
FI963645A 1994-03-16 1996-09-16 Silmän sisäistä painetta alentavan aineen käyttö ja silmätipoiksi tehty lääke FI114897B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4540494 1994-03-16
JP4540494 1994-03-16
JP9500444 1995-03-16
PCT/JP1995/000444 WO1995024902A1 (fr) 1994-03-16 1995-03-16 Reducteur de tension oculaire

Publications (3)

Publication Number Publication Date
FI963645A0 FI963645A0 (fi) 1996-09-16
FI963645A FI963645A (fi) 1996-11-14
FI114897B true FI114897B (fi) 2005-01-31

Family

ID=12718322

Family Applications (2)

Application Number Title Priority Date Filing Date
FI963645A FI114897B (fi) 1994-03-16 1996-09-16 Silmän sisäistä painetta alentavan aineen käyttö ja silmätipoiksi tehty lääke
FI20041236A FI115197B (fi) 1994-03-16 2004-09-24 Yhdisteen käyttö silmälääkkeen valmistamiseksi yhdistelmänä beta-salpaajan kanssa ja silmätipoiksi tehty, silmissä paikallisesti käytettävä lääke

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20041236A FI115197B (fi) 1994-03-16 2004-09-24 Yhdisteen käyttö silmälääkkeen valmistamiseksi yhdistelmänä beta-salpaajan kanssa ja silmätipoiksi tehty, silmissä paikallisesti käytettävä lääke

Country Status (20)

Country Link
US (1) US5925664A (ko)
EP (2) EP0795326B1 (ko)
KR (1) KR100211446B1 (ko)
CN (2) CN1104898C (ko)
AT (2) ATE266402T1 (ko)
AU (1) AU684916B2 (ko)
CZ (1) CZ284395B6 (ko)
DE (2) DE69533045T2 (ko)
DK (2) DK0795326T3 (ko)
ES (2) ES2163501T3 (ko)
FI (2) FI114897B (ko)
GR (1) GR3036989T3 (ko)
HK (1) HK1000551A1 (ko)
HU (1) HUT74734A (ko)
MX (1) MX9604109A (ko)
NO (1) NO311068B1 (ko)
NZ (1) NZ282485A (ko)
PT (2) PT795326E (ko)
RU (1) RU2123847C1 (ko)
WO (1) WO1995024902A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245639B (en) 1999-06-11 2005-12-21 Sankyo Co Eye-pressure reducing composition for local administration
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
ES2535291T3 (es) * 2003-04-15 2015-05-08 Daiichi Sankyo Company, Limited Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
ZA875052B (en) * 1986-07-11 1989-03-29 Du Pont Angiotensin ii receptor blocking imidazoles
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
ATE134368T1 (de) * 1989-06-30 1996-03-15 Du Pont Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
IE920540A1 (en) * 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
PT573218E (pt) * 1992-06-02 2001-06-29 Sankyo Co 4-carbonilimidazoles como antagonistas de angiotensina ii e sua utilizacao terapeutica
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
JP3501484B2 (ja) * 1992-12-17 2004-03-02 三共株式会社 ビフェニル誘導体
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
CN1140409A (zh) * 1994-02-08 1997-01-15 希巴-盖吉股份公司 血管紧张素ii拮抗剂对正常眼压性青光眼的治疗

Also Published As

Publication number Publication date
CN1202819C (zh) 2005-05-25
ES2221872T3 (es) 2005-01-16
US5925664A (en) 1999-07-20
AU1960295A (en) 1995-10-03
NO311068B1 (no) 2001-10-08
NZ282485A (en) 1997-06-24
EP0795326A1 (en) 1997-09-17
EP0795326B1 (en) 2001-09-26
EP0795326A4 (ko) 1997-09-17
ATE206050T1 (de) 2001-10-15
DE69533045D1 (de) 2004-06-17
MX9604109A (es) 1997-09-30
DE69522955D1 (de) 2001-10-31
PT795326E (pt) 2002-01-30
FI963645A0 (fi) 1996-09-16
DE69522955T2 (de) 2002-05-29
WO1995024902A1 (fr) 1995-09-21
EP1110551A3 (en) 2001-08-16
NO963854L (no) 1996-11-14
CZ284395B6 (cs) 1998-11-11
CN1148809A (zh) 1997-04-30
EP1110551B1 (en) 2004-05-12
HK1000551A1 (en) 2002-04-12
ES2163501T3 (es) 2002-02-01
NO963854D0 (no) 1996-09-13
GR3036989T3 (en) 2002-01-31
DK1110551T3 (da) 2004-06-07
ATE266402T1 (de) 2004-05-15
DE69533045T2 (de) 2005-01-27
RU2123847C1 (ru) 1998-12-27
EP1110551A2 (en) 2001-06-27
CN1387846A (zh) 2003-01-01
KR970701542A (ko) 1997-04-12
FI20041236A (fi) 2004-09-24
FI963645A (fi) 1996-11-14
HUT74734A (en) 1997-02-28
DK0795326T3 (da) 2001-11-26
KR100211446B1 (ko) 1999-08-02
CN1104898C (zh) 2003-04-09
HU9602534D0 (en) 1996-11-28
FI115197B (fi) 2005-03-31
PT1110551E (pt) 2004-07-30
CZ269496A3 (en) 1996-12-11
AU684916B2 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
AU773110B2 (en) Concomitant drugs for treating glaucoma
FI114897B (fi) Silmän sisäistä painetta alentavan aineen käyttö ja silmätipoiksi tehty lääke
CA2185524C (en) Ocular tension depressant
AU759513B2 (en) Ocular tension lowering composition for topical administration
JP2826077B2 (ja) 眼圧低下剤
AU2004200751A1 (en) Combined agents for treatment of glaucoma

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114897

Country of ref document: FI